| 1 |
WHO. WHO Coronavirus Disease (COVID-19) Dashboard [EB/OL]. (2022-06-13) [2022-07-15].
URL
|
| 2 |
COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis [J]. Lancet, 2022, 399(10334): 1469-1488.
|
| 3 |
Salinas-Aguirre JE, Sanchez-Garcia C, Rodriguez-Sanchez R, et al. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico) [J]. Rev Clin Esp (Barc), 2022, 222(5): 288-292.
|
| 4 |
Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China [J]. Mech Ageing Dev, 2020, 188: 111255.
|
| 5 |
Duggan MC, Van J, Ely EW. Delirium assessment in critically ill older adults: considerations during the COVID-19 pandemic [J]. Crit Care Clin, 2021, 37(1): 175-190.
|
| 6 |
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019 [J]. N Engl J Med, 2020, 382(8): 727-733.
|
| 7 |
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy [J]. JAMA, 2020, 323(18): 1775-1776.
|
| 8 |
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area [J]. JAMA, 2020, 323(20): 2052-2059.
|
| 9 |
Tsukagoshi H, Shinoda D, Saito M, et al. Relationships between viral load and the clinical course of COVID-19 [J]. Viruses, 2021, 13(2): 304.
|
| 10 |
Nicoli F, Solis-Soto MT, Paudel D, et al. Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity [J]. Geroscience, 2020, 42(4): 1015-1019.
|
| 11 |
Singhal S, Kumar P, Singh S, et al. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis [J]. BMC Geriatr, 2021, 21(1): 321.
|
| 12 |
Alves VP, Casemiro FG, Araujo BG, et al. Factors associated with mortality among elderly people in the COVID-19 pandemic (SARS-CoV-2): a systematic review and meta-analysis [J]. Int J Environ Res Public Health, 2021, 18(15): 8008.
|
| 13 |
Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study [J]. Lancet, 2021, 397(10270): 220-232.
|
| 14 |
Geen O, Rochwerg B, Wang XM. Optimizing care for critically ill older adults [J]. CMAJ, 2021, 193(39): E1525-E1533.
|
| 15 |
国家卫生健康委, 国家中医药管理局. 新型冠状病毒肺炎诊疗方案(试行第九版) [EB/OL].(2022-06-28)[2022-07-15].
URL
|
| 16 |
Najjar-Debbiny R, Gronich N, Weber G, et al. Effectiveness of Paxlovid in reducing severe COVID-19 and mortality in high risk patients [J]. Clin Infect Dis, 2022, 2: ciac443.
|
| 17 |
Libster R, Perez Marc G, Wappner D, et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults [J]. N Engl J Med, 2021, 384(7): 610-618.
|
| 18 |
Pan C, Chen H, Xie J, et al. The efficiency of convalescent plasma therapy in the management of critically ill patients infected with COVID-19: a matched cohort study [J]. Front Med (Lausanne), 2022, 9: 822821.
|
| 19 |
Falcone M, Tiseo G, Valoriani B, et al. Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in preventing progression to severe COVID-19 and role of variants of concern [J]. Infect Dis Ther, 2021, 10(4): 2479-2488.
|
| 20 |
Sun Q, Qiu H, Huang M, et al. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province [J]. Ann Intensive Care, 2020, 10(1): 33.
|
| 21 |
Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study [J]. Lancet Microbe, 2020, 1(6): e245-e253.
|
| 22 |
Di Minno A, Ambrosino P, Calcaterra I, et al. COVID-19 and venous thromboembolism: a meta-analysis of literature studies [J]. Semin Thromb Hemost, 2020, 46(7): 763-771.
|
| 23 |
Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study [J]. Clin Microbiol Infect, 2021, 27(1): 83-88.
|
| 24 |
Perez-Granda MJ, Carrillo CS, Rabadan PM, et al. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control [J]. J Hosp Infect, 2022, 119: 149-154.
|
| 25 |
Bashardoust P, Fano BJ. Incidence of COVID-19-associated venous thromboembolism among hospitalized patients in McAllen, Texas, USA, in Late 2021 [J]. Cureus, 2022, 14(3): e23270.
|
| 26 |
Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [J]. Thromb Res, 2020, 191: 145-147.
|
| 27 |
Amini M, Mansouri F, Vafaee K, et al. Factors affecting the incidence and prevalence of pressure ulcers in COVID-19 patients admitted with a Braden scale below 14 in the intensive care unit: Retrospective cohort study [J]. Int Wound J, 2022, 2: 1-16.
|
| 28 |
Kottner J, Cuddigan J, Carville K, et al. Prevention and treatment of pressure ulcers/injuries: the protocol for the second update of the international clinical practice guideline 2019 [J]. J Tissue Viability, 2019, 28(2): 51-58.
|
| 29 |
Goodwin VA, Allan L, Bethel A, et al. Rehabilitation to enable recovery from COVID-19: a rapid systematic review [J]. Physiotherapy, 2021, 111: 4-22.
|
| 30 |
Lithander FE, Neumann S, Tenison E, et al. COVID-19 in older people: a rapid clinical review [J]. Age Ageing, 2020, 49(4): 501-515.
|
| 31 |
Cimerman M, Jesensek Papez B. The impact of COVID-19 pandemic on the rehabilitation of patients after arthroscopic knee surgery at IPRM in UCM Maribor, Slovenia [J]. Bratisl Lek Listy, 2022, 123(4): 262-267.
|
| 32 |
Santini ZI, Jose PE, York Cornwell E, et al. Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis [J]. Lancet Public Health, 2020, 5(1): e62-e70.
|